Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.58%397B | 1.29%271.47B | 0.00%135.5B | 3.09%529.42B | 2.72%394.72B | 2.82%268.01B | 3.76%135.49B | 6.67%513.55B | 6.45%384.25B | 7.57%260.66B |
| Operating income | 0.58%397B | 1.29%271.47B | 0.00%135.5B | 3.09%529.42B | 2.72%394.72B | 2.82%268.01B | 3.76%135.49B | 6.67%513.55B | 6.45%384.25B | 7.57%260.66B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Selling expenses | -1.47%-49.27B | 0.93%-32.78B | -0.55%-16.76B | 0.21%-66.66B | 0.54%-48.56B | -0.76%-33.09B | -3.17%-16.67B | -3.93%-66.8B | -2.93%-48.83B | -2.54%-32.84B |
| Employee expense | 0.29%-75.22B | 0.25%-50.44B | 2.03%-28.2B | -5.90%-98.28B | -2.27%-75.44B | -3.20%-50.57B | -4.76%-28.79B | -9.48%-92.81B | -9.88%-73.76B | -9.82%-49B |
| Depreciation and amortization | -4.36%-77.89B | -5.06%-52.04B | -5.86%-25.99B | -1.35%-101.04B | -3.94%-74.64B | -3.54%-49.53B | -2.83%-24.55B | -2.86%-99.7B | -2.38%-71.81B | -2.36%-47.84B |
| Special items of operating profit | 1.77%-156.88B | -0.09%-107.66B | 2.07%-53.8B | -3.00%-223.63B | -2.36%-159.7B | -1.97%-107.56B | -3.50%-54.93B | -7.46%-217.11B | -6.89%-156.02B | -10.07%-105.48B |
| Operating profit | 3.72%37.74B | 4.73%28.55B | 1.86%10.75B | 7.20%39.8B | 7.53%36.38B | 6.87%27.26B | 5.50%10.55B | 11.07%37.13B | 11.61%33.84B | 10.36%25.51B |
| Financing cost | 12.36%-454M | -17.60%-294M | 40.97%-85M | 31.33%-228M | 12.20%-518M | 48.24%-250M | 51.02%-144M | -4,642.86%-332M | -2,085.19%-590M | -1,510.00%-483M |
| Share of profits of associates | 11.37%1.96B | 7.69%1.23B | 1.73%648M | 19.33%2.53B | 14.07%1.76B | 14.96%1.15B | 23.69%637M | 3.17%2.12B | 10.14%1.54B | 19.57%996M |
| Special items of earning before tax | 136.78%206M | 27.38%107M | -84.44%7M | -75.34%72M | -61.33%87M | -47.17%84M | -28.57%45M | 20.16%292M | 59.57%225M | 1,666.67%159M |
| Earning before tax | 4.61%39.45B | 4.80%29.6B | 2.06%11.32B | 7.57%42.17B | 7.71%37.71B | 7.86%28.24B | 7.82%11.09B | 9.77%39.2B | 10.00%35.01B | 9.43%26.18B |
| Tax | -3.67%-8.68B | -4.83%-6.58B | -1.14%-2.49B | -4.80%-9.2B | -6.37%-8.37B | -4.45%-6.27B | -6.40%-2.46B | -9.18%-8.78B | -9.41%-7.87B | -7.79%-6.01B |
| After-tax profit from continuing operations | 4.88%30.77B | 4.79%23.02B | 2.32%8.83B | 8.37%32.98B | 8.09%29.34B | 8.88%21.97B | 8.23%8.63B | 9.94%30.43B | 10.17%27.14B | 9.92%20.17B |
| Earning after tax | 4.88%30.77B | 4.79%23.02B | 2.32%8.83B | 8.37%32.98B | 8.09%29.34B | 8.88%21.97B | 8.23%8.63B | 9.94%30.43B | 10.17%27.14B | 9.92%20.17B |
| Minority profit | -104.88%-2M | -98.70%2M | -216.13%-36M | -105.56%-37M | -2.38%41M | 633.33%154M | 358.33%31M | -121.69%-18M | -55.32%42M | -66.13%21M |
| Profit attributable to shareholders | 5.03%30.77B | 5.52%23.02B | 3.11%8.86B | 8.43%33.01B | 8.11%29.3B | 8.23%21.81B | 7.68%8.6B | 10.34%30.45B | 10.42%27.1B | 10.18%20.15B |
| Basic earnings per share | 6.25%0.34 | 4.17%0.25 | 11.11%0.1 | 9.09%0.36 | 6.67%0.32 | 9.09%0.24 | 0.00%0.09 | 10.00%0.33 | 11.11%0.3 | 10.00%0.22 |
| Diluted earnings per share | 6.25%0.34 | 4.17%0.25 | 11.11%0.1 | 9.09%0.36 | 6.67%0.32 | 9.09%0.24 | 0.00%0.09 | 10.00%0.33 | 11.11%0.3 | 10.00%0.22 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.